Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma

Gynecologic Oncology

Volumn 81, Issue 3, 2001, Pages 404-407

  Pattaranutaporn, P ^a   Thirapakawong, C ^a   Chansilpa, Y ^a   Therasakvichya, S ^a   Ieumwananontachai, N ^a   Thephamongkhol, K ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cervical carcinoma; Concurrent chemoradiation; Gemcitabine

Indexed keywords

GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; METASTASIS; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0034980415     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6197     Document Type: Article

References (28)

1. The patterns of care outcome study for cancer of the uterine cervix. Results of the Second National Practice Survey
2. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French cooperative study: Update and multivariate analysis of prognostics factors
3. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of cervix
4. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association
5. Hydroxyurea or placebo combined with radiation to treat stage IIIB and IV cervical cancer confined to the pelvis
6. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: A phase I-II prospective intergroup NCOG-RTOG Study
7. Concurrent radiation therapy, cis-platinum and mitomycin C in patients with poor prognosis cancer of the cervix: A pilot study
8. Gemcitabine: Preclinical pharmacology and mechanisms of action
9. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
10. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer
11. Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
12. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer
13. Gemcitabine and radiosensitization in human tumor cells
14. Radiosenzitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro
15. Gemcitabine-mediated radiosensitizer
16. Gemzar® (gemcitabine) with thoracic radiotherapy - A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC)
17. A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unrectable stage III non-small cell lung cancer (NSCLC) (CALGB study 9431)
18. Gemcitabine plus radiotherapy in stage II-III pancreatic cancer: A phase I trial
19. A phase IB study of gemcitabine (GEM) and concurrent radiotherapy (RT) in advanced carcinoma of the cervix
20. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
21. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
22. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
23. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
24. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern Italy Cooperative Oncology Group
25. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial
26. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma